Zoledronate prevents fractures in older women when administered every 12 to 18 months, but its effects on bone density and bone turnover persist beyond 5 years. Whether infrequent zoledronate ...
in JAMA Network Open. Nonetheless, their study showed that a first fracture at any decade of life was associated with an increased fracture risk following bone mineral density testing ...